MASH disease: From silent epidemic to treatment options
Liver disease is a growing global health concern, yet many of its most serious forms remain...
Liver disease is a growing global health concern, yet many of its most serious forms remain...
by: Alexandra Miller, MPH Human papillomavirus (HPV) is one of the most common sexually...
Closed claims no longer reflect real-world GLP-1 treatment patterns GLP-1 utilization continues to...
As the new year begins, many patients refocus on weight management and long-term health goals. At...
Artificial intelligence is no longer something healthcare and life sciences teams are testing on...
October is Breast Cancer Awareness Month. While pink ribbons and fundraising campaigns help bring...
Few areas of medicine have captured public interest over the past two years quite like...
AI-driven mortality models are supposed to provide accurate, data-backed insights into patient...
GLP-1 Trends: Ozempic and Semaglutide drive a 587% spike in prescriptions Prescriptions for GLP-1...
FDA's AI guidance is reshaping real-world data standards Artificial Intelligence (AI) is rapidly...
Liver disease is a growing global health concern, yet many of its most serious forms remain under-recognized and underdiagnosed. Metabolic dysfunction-associated steatohepatitis (MASH) stands out as a particularly urgent challenge. MASH disease is a ...